DSpace Repository

Neuritogenic activity of bi-functional bis-tryptoline triazole

Show simple item record

dc.contributor.author Jiaranaikulwanitch J.
dc.contributor.author Tadtong S.
dc.contributor.author Govitrapong P.
dc.contributor.author Fokin V.V.
dc.contributor.author Vajragupta O.
dc.date.accessioned 2021-04-05T03:23:09Z
dc.date.available 2021-04-05T03:23:09Z
dc.date.issued 2017
dc.identifier.issn 9680896
dc.identifier.other 2-s2.0-85009471336
dc.identifier.uri https://ir.swu.ac.th/jspui/handle/123456789/13301
dc.identifier.uri https://www.scopus.com/inward/record.uri?eid=2-s2.0-85009471336&doi=10.1016%2fj.bmc.2016.12.027&partnerID=40&md5=76a77627d1f357759b68ebc7ff292c3a
dc.description.abstract Alzheimer's disease (AD) is a common neurodegenerative disorder, one of the hallmarks of which is the deposition of aggregated β-amyloid peptides (Aβ40,42) as plaques in the brain. Oligomers of these peptides have been reported to be toxic and to inhibit neurite outgrowth, as evidenced by neurite dystrophy and significant loss of synaptic connectivity of neurons in the AD brain resulting in cognitive decline. These peptides also react with biological metal in the brain to generate free radicals, thereby aggravating neuronal cell injury and death. Herein, multifunctional triazole-based compounds acting on multiple targets, namely β-secretase (BACE1), β-amyloid peptides (Aβ) as well as those possessing metal chelation and antioxidant properties, were developed and evaluated for neuritogenic activity in P19-derived neurons. At the non-cytotoxic concentration (1 nM), all multifunctional compounds significantly enhanced neurite outgrowth. New bis-tryptoline triazole (BTT) increased the neurite length and neurite number, by 93.25% and 136.09% over the control, respectively. This finding demonstrates the ability of multifunctional compounds targeting Aβ to enhance neurite outgrowth in addition to their neuroprotective action. © 2016 Elsevier Ltd
dc.subject amyloid beta protein
dc.subject beta secretase
dc.subject bis tryptoline triazole derivative
dc.subject geldanamycin
dc.subject quercetin
dc.subject triazole derivative
dc.subject unclassified drug
dc.subject aspartic proteinase
dc.subject BACE1 protein, human
dc.subject carboline derivative
dc.subject enzyme inhibitor
dc.subject neuroprotective agent
dc.subject secretase
dc.subject triazole derivative
dc.subject tryptoline
dc.subject antioxidant activity
dc.subject Article
dc.subject chelation
dc.subject concentration response
dc.subject controlled study
dc.subject cytotoxicity
dc.subject drug activity
dc.subject drug screening
dc.subject drug structure
dc.subject drug targeting
dc.subject nerve cell
dc.subject neurite outgrowth
dc.subject neuritogenic activity
dc.subject neuroprotection
dc.subject animal
dc.subject antagonists and inhibitors
dc.subject cell line
dc.subject cell survival
dc.subject chemical structure
dc.subject chemistry
dc.subject dose response
dc.subject drug effects
dc.subject human
dc.subject metabolism
dc.subject mouse
dc.subject neurite
dc.subject structure activity relation
dc.subject synthesis
dc.subject Amyloid Precursor Protein Secretases
dc.subject Animals
dc.subject Aspartic Acid Endopeptidases
dc.subject Carbolines
dc.subject Cell Line
dc.subject Cell Survival
dc.subject Dose-Response Relationship, Drug
dc.subject Enzyme Inhibitors
dc.subject Humans
dc.subject Mice
dc.subject Molecular Structure
dc.subject Neurites
dc.subject Neuroprotective Agents
dc.subject Structure-Activity Relationship
dc.subject Triazoles
dc.title Neuritogenic activity of bi-functional bis-tryptoline triazole
dc.type Article
dc.rights.holder Scopus
dc.identifier.bibliograpycitation Bioorganic and Medicinal Chemistry. Vol 25, No.3 (2017), p.1195-1201
dc.identifier.doi 10.1016/j.bmc.2016.12.027


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics